MoneyWorks4Me

Sun Pharmaceutical Industries informs about transcript of conference call

11 Nov 2025 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharmaceutical Industries has informed that it enclosed a copy of the transcript of the Company’s Q2FY26 earnings conference call, which the company shall be uploading on its website after sending this letter.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1792.20
Dr. Reddys Labs. 1198.80
Cipla 1333.45
Lupin 2015.00
Zydus Lifesciences 1145.05
View more..